Axogen (AXGN) Research & Development (2010 - 2026)

Axogen has reported Research & Development for 17 years, with the latest figure at $30.8 million in Q2 2026.

• On a quarterly basis, Research & Development rose 29.5% year-over-year to $30.8 million in Q2 2026; TTM through Jun 2026 was $112.4 million, a 34.08% increase from a year earlier, with the FY2025 full-year figure at $97.7 million, up 24.57% from the prior year.
• Research & Development was $30.8 million for Q2 2026 at Axogen, up from $28.6 million in the prior quarter.
• The five-year high for Research & Development was $30.8 million in Q2 2026, with the low at $11.6 million in Q4 2022.
• Average Research & Development over 5 years is $21.4 million, with a median of $19.9 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Research & Development slumped 34.4% in 2022, then soared 72.85% in 2023.
• Over 5 years, Research & Development stood at $11.6 million in 2022, then jumped by 72.85% to $20.1 million in 2023, then slipped by 0.42% to $20.0 million in 2024, then jumped by 35.89% to $27.2 million in 2025, then increased by 13.29% to $30.8 million in 2026.
• The last three Research & Development figures came in at $30.8 million (Q2 2026), $28.6 million (Q1 2026), and $27.2 million (Q4 2025), per Business Quant data.